| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 49.5953 | 47 |
| GSM780708 | Untreated after 4 days (C2_1) | 59.1265 | 64 |
| GSM780709 | Untreated after 4 days (C3_1) | 43.2008 | 18 |
| GSM780719 | Untreated after 4 days (C1_2) | 54.8718 | 59 |
| GSM780720 | Untreated after 4 days (C2_2) | 54.8402 | 59 |
| GSM780721 | Untreated after 4 days (C3_2) | 63.0982 | 66 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 53.0207 | 56 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 50.6636 | 50 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 59.7098 | 64 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 52.6215 | 55 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.2363 | 28 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 53.121 | 56 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.3986 | 50 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 54.7434 | 59 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 57.9235 | 63 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 50.6307 | 50 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 51.091 | 52 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.1416 | 28 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 54.7563 | 59 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.3891 | 34 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 49.817 | 48 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 49.2836 | 46 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 50.6005 | 50 |